Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful

View/ Open
Author
Keraliya, Abhishek R.
Tirumani, Sree Harsha
Lele, Vikram R.
Published Version
https://doi.org/10.3348/kjr.2017.18.1.54Metadata
Show full item recordCitation
Shah, Hina J., Abhishek R. Keraliya, Jyothi P. Jagannathan, Sree Harsha Tirumani, Vikram R. Lele, and Pamela J. DiPiro. 2017. “Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful.” Korean Journal of Radiology 18 (1): 54-70. doi:10.3348/kjr.2017.18.1.54. http://dx.doi.org/10.3348/kjr.2017.18.1.54.Abstract
Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has emerged as the most important imaging tool to guide oncologists in the diagnosis, staging, response assessment, relapse/recurrence detection,and therapeutic decision making of DLBCL. Other imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and conventional radiography are also used in the evaluation of lymphoma. MRI is useful for nervous system and musculoskeletal system involvement and is emerging as a radiation free alternative to PET/CT. This article provides a comprehensive review of both the functional and morphological imaging modalities, available in the management of DLBCL.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240489/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:30371025
Collections
- HMS Scholarly Articles [17298]
Contact administrator regarding this item (to report mistakes or request changes)